Clinical Trial 45748

Gaithersburg, MD 20877


This is a placebo-controlled outpatient study that assess the efficacy of an investigational compound for the treatment of Schizophrenia. The study consists of a 12-week treatment period, in which participants will be assigned to receive the investigational compound or placebo. Following completion of the treatment period, there is 2-week follow up period.

Qualified Participants Must:

• Be between the ages of 18-55
• Have a diagnosis of Schizophrenia
• Have no recent hospitalizations for worsening of schizophrenia symptoms
• Be on treatment with antipsychotics
• Be medically stable

Qualified Participants May Receive:

Compensation is available for all study participants

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.